Chronic endometritis and altered embryo implantation: a unified pathophysiological theory from a literature systematic review



Chronic endometritis (CE) is a frequent hysteroscopic and histological finding which affects embryo transfer implantation during IVF-ICSI cycles. In particular, CE impairs proper decidualization and, subsequently, implantation. Although this correlation has been clearly clarified, a pathophysiological explanation assembling all the studies performed has not been elucidated yet. For this reason, we have structured a systematic review considering all the original articles that evaluated a pathological element involved in CE and implantation impairment.


The authors searched electronic databases and, after screening, collected 15 original articles. These were fully scanned and used to create a summary pathway.


CE is primarily caused by infections, which lead to a specific cytokine and leukocyte pattern in order to prepare the uterus to fight the noxa. In particular, the immunosuppression requested for a proper semi-allogenic embryo transfer implantation is converted into an immunoreaction, which hampers correct embryo implantation. Moreover, endometrial vascularization is affected and both irregular vessel density and luminal thickening and thrombosis reduce what we have first identified as endometrial flow reserve. Finally, incorrect uterine wave propagation could affect embryo contact with decidua.


This is the first summary of evidence on CE pathophysiology and its relationship with infertility. Understanding the CE pathophysiology could improve our knowledge in embryo transfer success.


Chronic endometritis (CE) is a persistent inflammatory disorder of the endometrial lining, characterized by superficial endometrial edematous change, high stromal cell density, dissociated maturation between epithelium and stroma, and infiltration of endometrial stromal plasmacytes (ESPCs) [1,2,3,4,5]. The pathogenesis of CE seems to be related to a qualitative and quantitative alteration of endometrial microbioma, with the abnormal proliferation of different types of microorganisms, mainly gram-negative and intracellular bacteria (i.e., Enterococcus faecalis, Mycoplasma, Ureaplasma, Chlamydia, Escherichia coli, and Streptococcus spp.) [2, 6,7,8,9]. As proof of the infectious etiology of CE, several studies have found that specific antibiotic cycles can cure CE in the majority of patients [1, 7, 10].

In most cases, women with CE are asymptomatic or display mild disturbances, such as abnormal uterine bleeding (AUB), dyspareunia, pelvic discomfort, and leukorrhea [11,12,13]. Moreover, CE cannot be identified by ultrasound examination due to a lack of specific ultrasound markers [8]. For these reasons, CE is often overlooked or diagnosed incidentally during the diagnostic workup of different gynecological disorders including AUB, infertility, or chronic pelvic pain [14].

Fluid hysteroscopy plays a central role in the diagnostic challenge of CE. This technique allows the identification of some endometrial modifications that are specific for CE (i.e., focal or diffuse micropolyps, stromal edema, focal hyperemia, strawberry aspect, and endometrial hemorrhagic spots), as recently demonstrated by our group [15].

The current gold standard for CE diagnosis is endometrial biopsy with histological analysis, where the detection of plasma cells within endometrial stroma is the main diagnostic marker [7]. A plasma cell is a type of white blood cell which is derived from B lymphocytes; it is capable of secreting immunoglobulins and is the main cell responsible for humoral immunity. Different studies have shown that traditional staining with hematoxylin and eosin (H&E) may be not sufficiently accurate for highlighting endometrial plasma cells due to their morphological similarities with fibroblasts. Differently, the immunohistochemical staining for CD138 was associated with lower intra- and interobserver variability between pathologists in the detection of plasma cells and has now become the reference standard technique for diagnosing CE [16,17,18].

During the last several decades, CE has attracted a great deal of attention among scientists and fertility care providers due to its potential association with reproductive issues. In particular, several studies have found that CE is highly prevalent among women suffering from unexplained infertility (from 40.7 to 55.7%), recurrent IVF failures (from 13.95 to 57.55%), and repeated early pregnancy loss (from 42.9 to 56%). Importantly, adequate therapy of CE can lead to a complete normalization of endometrial histology and to the restoration of the reproductive function in women with CE [19,20,21,22,23,24].

In recent years, many authors have investigated the possible mechanisms by which CE may hamper the reproductive health of the endometrium, but the pathophysiological pathway has not been fully assessed yet. In this present study, we aimed to provide the first summary of evidence on the pathophysiological mechanisms involved in CE-related reproductive impairment.

Materials and methods

Study design

This is a systematic literature review on the pathophysiological mechanisms involved in CE-related reproductive issues. As it was a review of published data, institutional review board approval was not required.

Search strategy

Electronic databases (ScienceDirect, MEDLINE, Scopus, Embase, the Cochrane Library,, EU Clinical Trials Register, and the World Health Organization International Clinical Trials Registry) were searched for articles indexed from the inception to September 2019. The search was conducted adopting the following keywords: “chronic endometritis AND (infertility OR fertile OR fertility OR miscarriage OR implantation failure OR implantation OR endometrial receptivity OR decidualization OR ART OR IVF OR mechanisms OR causes OR pathway OR pathophysiology).” Furthermore, the reference list of all identified articles and reviews were accurately examined to avoid any missing data.

Inclusion criteria

All the studies assessing the pathophysiology of infertility in women with CE were evaluated. Chronic endometritis was defined as a chronic inflammation of endometrium, diagnosed by the histologic presence of one or more plasma cells in the endometrial stroma in the entire section. Articles evaluating other types of endometrial inflammation (such as acute, subacute, or tubercular endometritis) were not included.

No restrictions on the year of publication were applied. The search and the selection criteria were restricted to English language and only studies with full text available were considered suitable for inclusion.

We included only original articles both on humans and animals. However, we did not find any animal study which matched our inclusion criteria. Reviews, systematic reviews and meta-analysis were excluded. The studies evaluated were primarily case-control studies, cohort studies, and retrospective studies.

Study selection and data extraction

The electronic and reference list searches were performed independently by G.B., R.C., and C.M.S. These investigators then screened titles and abstracts. The results were then compared and any disagreement was resolved by discussion with other reviewers (E.C. and A.V.).

Included studies

The electronic search identified 419 records. Forty-one full-text articles were evaluated, of which 26 were excluded. A total of 15 manuscripts were considered eligible for inclusion in the study. Table 1 shows the main characteristics of the studies considered.

Table 1 Main characteristics of the studies enrolled

Fifteen studies performed hysteroscopy (Carvalho 2013 Cicinelli 2008, Cicinelli 2009, Di Pietro 2013 Di Pietro 2018, Kitaya 2010, Kitaya 2014, Kushnir 2016, Liu 2019, Matteo 2009, Mishra 2008, Moreno 2018, Pinto 2015, Wang 2019, Wu 2017). One study performed vaginal swab (Cicinelli 2008). Nine studies performed biopsy via Novak curettage (Cicinelli 2008, Cicinelli 2009, Di Pietro 2013, Kitaya 2014, Matteo 2009, Mishra 2008, Moreno 2018, Wang 2008, Wu 2017). On the other hand, 2 studies performed biopsy via Pipelle (Di Pietro 2018, Liu 2019). One study performed blind endometrial biopsy (Carvalho 2013).

The time of intervention was different. Carvalho (2013) performed biopsy between 10 and 5 days post ovulation. Cicinelli (2008, 2009), Di Pietro (2018), Matteo (2009), and Moreno (2018) carried out the biopsy during the follicular phase. By contrast, Di Pietro (2013) and Mishra (2008) performed the intervention in the secretive phase. Liu (2019) administered biopsy on day 7 from luteinizing hormone (LH) surge. Kitaya (2010) performed biopsy from days 6 to 8 post LH surge. Kitaya (2014) conducted the procedure from days 6 to 12 post period, and Wang (2019) from day 8 to 12 post period. Wu (2017) from days 7 to 8 after predicted ovulation. Finally, Matteo (2009) performed biopsy on the late secretive phase.

Moreover, in order to perform a microbiological study, 4 studies used cultures (Cicinelli 2008, Cicinelli 2009, Moreno 2018 and Wu 2017).

Only one study performed vaginal ultrasound evaluation (Pinto 2015).

Gene expression profiling RT-PCR was used in 8 studies (Cicinelli 2008, Cicinelli 2009, Di Pietro 2013, Di Pietro 2018, Liu 2019, Moreno 2018, Wang 2019, Wu 2017). Three studies used immunohistochemistry (Mishra 2008, Wang 2019, Wu 2017). Three studies used immunoassay (Kitaya 2014, Wang 2019, Wu 2017). One study examined serum (Kushnir 2016) and another study performed antibody labeling and flow cytometry (Matteo 2009).

Results and discussion

Chronic endometritis (CE) is a disease characterized by one main feature: inflammation. Actually, while the biopsy findings are defined and classified, the pathophysiological pathway is still unclear. Moreover, the relationship between CE and infertility or repeated implantation failure is still under investigation.

Firstly, it must be considered that implantation is the result of a complex interaction between the blastocyst and the endometrium. Different signaling pathways participate in this unique biological link and an appropriate endometrium is requested for the implantation success. This unstable balance can easily be altered by embryonic factors (and this is not our study concern) or endometrial factors. In this case, CE is what inhibits the endometrial ability to achieve a successful implantation.

Our pathophysiological model starts with the following consideration: CE inflammation is mainly caused by infection. Different microorganisms have been detected and various antibiotic protocols have enhanced IVF success after administration in CE infertile women. However, we are of the opinion that the infection is only a trigger of a more complex sequence that consists of an academically organized flowchart.

An altered cytokine and chemokine secretion induces altered leukocyte population recruitment. These two conditions impact on uterine contractility, endometrial function in decidualization, and receptivity and vascularization. The main role is played by autophagy, which is necessary for achieving implantation.

Infection and autoimmunity

In the majority of patients with CE, microbiological analyses (cultures or RT-PCR analyses) are positive for endometrial microorganisms. However, there are also specific cases in which we are unable to identify any microorganisms, or the microorganism is not culturable, raising the doubt of a possible autoimmune pathogenesis of CE. It is to be noted that CE is characterized by plasma cell infiltrates, which are associated with practically all organ autoimmune responses, including rare autoimmune diseases of the reproductive system (i.e., autoimmune oophoritis). To test the hypothesis of CE as an autoimmune condition, a recent study (Kushnir et al. 2016) [25] compared different inflammatory and autoimmune markers between infertile women with CE versus infertile women without CE. The authors failed to demonstrate different values of total immunoglobulins, antinuclear antibodies, thyroid antibodies, and antiphospholipid antibodies between the two groups under comparison (p > 0.05), drawing the conclusion that CE does not have a substantial autoimmune component. Although these results need further confirmation, the hypothesis of an autoimmune-driven CE cannot be sustained at present. Accordingly, our model starts considering infections as the main immune trigger for CE.

As is already known, the uterine cavity is not sterile in physiological conditions, but is inhabited by a plethora of microorganisms mainly belonging to Lactobacilli species. Therefore, the isolation of endometrial microorganisms does not necessarily correlate with endometrial inflammation [26]. Cicinelli et al. investigated CE microorganisms by performing both hysteroscopic and histologic exams, in addition to endometrial and vaginal cultures [2, 9]. The findings can be summarized as follows:

  1. 1

    CE endometrium showed a prevalence of common bacteria. In particular, streptococci were found in 27.9% of cases and bacteria from intestinal flora (Enterococcus faecalis and Escherichia coli) were detected in 25.5% of cases. Ureaplasma urealyticum was detected in 10.0%, and Chlamydia in only 2.7% of cases. No cases of N. gonorrhoeae were found.

  2. 2

    Endometrial, vaginal, and endocervical cultures in CE women were compared to investigate the percentage of concordance with the etiologic agent. There was a statistically significant difference for Streptococcus, Staphylococcus, E. faecalis, and U. urealyticum (which were found to be more prevalent in vaginal than in endometrial samples).

  3. 3

    Both vaginal and endocervical cultures have low concordance with endometrial cultures. In particular, positive Staphylococcus endometrial cultures did not have any positive vaginal findings. On the other hand, Chlamydia has a 100% concordance between endometrial culture and endocervical culture. By contrast, in the majority of cases which proved positive for Ureaplasma and yeast, the microorganisms were also detected at the vaginal level.

However, bacteriological cultures are limited to those microorganisms that are able to grow under traditional culture. About 10% of cultures were negative in the endometrium suffering from CE (with histological diagnosis), and this was ascribable to the presence of other microorganisms (viruses or non-culturable bacteria) or the presence of autoimmune factors.

Moreno (2018) reported other results. In particular, streptococci were the most abundant bacteria detected (47%), followed by enterococci (15%), E. coli (12%), K. pneumoniae (5%), staphylococci (3%), and Mycoplasma hominis (2%) [8]. These results are quite similar to previous findings and, specifically, it is generally accepted that streptococci are the most prevalent microorganism in CE endometrium. Interestingly, G. vaginalis was detected in 7% of the samples analyzed and this is in line with Liu 2019, who found an increase in CE endometrium [27]. On the other hand, C. trachomatis and N. gonorrhoeae were undetectable in all tested samples, which is in agreement with the limited role of sexually transmitted disease in the CE pathogenesis of previous studies [8].

Liu (2019) studied CE microbioma on the 7th day after the LH peak (midluteal phase), the most favorable period for possible implantation, with PCR [27]. The main findings are that CE endometrial cavity shows a lower percentage of Lactobacillus species which are negatively correlated with Gardnerella, Anaerococcus, Finegoldia, and Staphylococcus. These are reported to be associated with preterm delivery and bacterial vaginosis. Lactobacillus species are, indeed, known to inhibit other bacteria by producing hydrogen peroxide and lactic acid. For this reason, Lactobacillus plays a major role as protective bacteria against dangerous microorganisms [28]. Table 2 summarizes the percentage of all the different species detected in these 4 studies [2, 8, 9, 27].

Table 2 microorganism percentage detected at CE biopsies

In conclusion, both an increase in dangerous microorganisms and a decrease in protective microorganisms can lead to potential uterine damage. The link between infections and the development of inflammation is a clear pathway step, since a vast number of studies have clarified that organ inflammation diseases can be caused by microorganisms. To clarify, HAV, HBV, and HCV are well-known causes of chronic hepatitis and this can lead both to cirrhosis and liver hepatocarcinoma. On the other hand, Alzheimer’s disease is now also related to viral infections such as Human herpesvirus 1 (HHV-1), Cytomegalovirus (CMV), and Human herpesvirus 2 (HHV-2) [29]. For this reason, it seems reasonable that an organ which is more prone to extra-corporeal contamination can also develop a chronic inflammatory disease. In particular, the link between infections and inflammation is the first step in our pathway and it is mediated by an interaction between inflammation stimuli such as microbial products, interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), and toll-like receptors (TLRs), IL-1 receptor (IL-1R), IL-6 receptor (IL-6R), and the TNF receptor (TNFR) [30]. Lipopolysaccharide, in particular, is the major component of the outer membrane of gram-negative bacteria and the ligand to toll-like receptor 4 expressed on their host cells. For this reason, lipopolysaccharide derived from gram-negative bacteria may be a trigger and mediator of chronic endometritis.

Cytokine dysregulation

Cytokines are inflammation mediators. Infection causes an aberrant local microenvironment due to an altered secretion of paracrine factors. Moreover, the endometrial microvascular endothelium plays a critical role by mediating the recruitment of leukocytes. In particular, the following signaling pathways have been reported in association with CE:

  1. 1

    CE downregulates IL-11 expression. A possible explanation can be found in miR-124-3p upregulation, which is a negative modulator of IL-11 [31, 32]. To clarify, IL-11 activity, binding to IL-11R alpha, helps trophoblast invasion by inducing endometrial epithelial adhesion molecule mRNA expression. Moreover, IL-11 plays a key role in decidualization, since it progresses progesterone-induced decidualization of human endometrial stromal cells, and in endometrial vascularization, promoting angiogenesis and/or remodeling of the maternal vasculature [33].

  2. 2

    CE downregulates CCL-4. CCL-4 is a chemokine that attracts natural killer (NK) cells and macrophages, whose activity is important for implantation, as they produce angiogenic factors, such as vascular endothelial growth factor (VEGF) promoting spiral artery remodeling which supports the implantation of the trophoblast. Specifically, CCL-4 can be responsible for uterine NK recruitment from plasma NK cells [31].

  3. 3

    CE upregulates IGFBP-1, whose expression is normally increased during decidualization [31]. However, Wu et al. (2017) found a discordant result regarding IGFBP-1 [34], which is downregulated in CE. In addition to this, it must be considered that IGFBP-1 is a modulator of trophoblast invasion, and specifically a negative modulator [35]. Probably, IGFBP-1 is a regulator of decidualization, acting as a damper of this complex interaction between embryo and decidua.

  4. 4

    CE downregulates IGF-1, which mediates the effects of estrogen on endometrial proliferation during the proliferative phase of the endometrial cycle. An explanation can be found on the role of miR-27a-3p, which is a negative modulator of IGF-1 and is upregulated in CE. A significant anti-correlation ratio was found for miR-27a-3p and IGF-1 [31, 32].

  5. 5

    CE upregulates both BCL-2 and BAX. BCL-2 inhibits CASP-8, which is a pro-apoptotic gene and has a role in endometrial decidualization. The BCL-2 overexpression in women with CE makes the endometrial cells more resistant to apoptosis. However, BAX partially counteracts BCL-2 [31]. It is possible that this is related to an unstable balance between proliferation and commitment of endometrial cells (see the “Altered autophagy” section).

  6. 6

    CE enhances selectin E expression in endometrial microvascular endothelium. Selectin E is not normally found in microvessels of non-pathological endometrium. In particular, selectin E expression is stimulated by IL1b, TNF-a, and lipopolysaccharide [24]. However, selectin E has a clarified role in trophoblast migration within decidual spiral arterioles. For this reason, we can infer that a correct balance between selectin E and other selectins (L or P) is necessary for successful implantation, and an excessive expression of selectin E leads to inappropriate trophoblast invasion [36].

  7. 7

    CE enhances CXCL13 expression in endometrial microvascular endothelium, when it is normally found only on endometrium surface. CXCL13 expression is only enhanced by lipopolysaccharide. It is likely that CXCL13 plays a role in selective recruitment of circulating naive B cells into the endometrium and has a key role on sustaining inflammation [24].

  8. 8

    CE enhances CXCL1 expression in endometrial glandular epithelium, when it is usually not detectable and confined in the stroma. CXCL1 expression is enhanced by lipopolysaccharide [24] and, as above, it can have a key role in attracting stromal B cells into glandular epithelium [37].

  9. 9

    In CE endometrium, there is an increase in IL-17 expression and a decrease in IL-10 and TGF-β1 expressions than in non-CE endometrium [38]. IL-10 and TGF-β1, in particular, are anti-inflammatory modulators and are secreted by Tregs. For this reason, they are both markers and mediators of a decreased inflammatory suppression and uNK cell recruitment [39].

Moreover, there is growing interest regarding the importance of mi-RNA regulation in CE. Recently, mi-RNA composition of exosomes has been studied in cows. In particular, exosomes are intercellular communication medium released by the endometrial epithelium into the uterine cavity and are involved in the transfer of signaling proteins (miRNAs and mRNAs) to either the embryo or adjacent endometrium. A difference between CE and non-CE endometrium has been identified, which requires further investigation. In particular, 118 miRNAs were found differentially expressed in the exosomes of cows without and those with endometritis. In those with CE, 52 miRNAs were found downregulated and 66 upregulated [40].

Women with CE have an altered endometrial expression in genes involved in inflammatory, cell proliferation, and apoptosis processes. CE is associated with shifted cytokine milieu toward Th17 over Treg immunity in endometrium. These findings support the notion that CE is associated with increased pro-inflammatory immune responses, which is often related to poor pregnancy outcomes [38]. CE upregulates both BCL-2 and BAX genes. As apoptosis is an important physiological mechanism in maintaining homeostasis during the menstrual cycle and in early phases of pregnancy, the altered anti- to pro-apoptotic factors ratio in women with CE could affect pregnancy-mediated tissue remodeling during blastocyst implantation and placental development in the uterus. Moreover, the prevalence of anti-apoptotic effect may explain the abnormal endometrial proliferation that is observed in women with CE, with the formation of endometrial micropolyps and, possibly, macropolyps [31]. Moreover, chronic inflammation may even predispose to endometrial carcinogenesis [41], even if this speculation needs robust scientific confirmation. CE is associated with the local release of different pro-inflammatory and oncogenic mediators such as nitric oxide (NO), cytokines (IL-1β, IL-2, IL-6, and TNF-α), growth factor, and chemokines. These mediators may make the endometrial inflammatory microenvironment more vulnerable toward tumorigenesis [42].

Leukocyte infiltration

After cytokine hyper-expression, a new microenvironment is created in the endometrium, whose primary aim is no longer implantation, but immune defense against an exogenous agent. In a normal endometrium, B cells can be found in endometrial stroma, but not in surface epithelium, glandular epithelium, or glandular lumina. In CE, B cells are recruited in the functional layer and single cells can be found between epithelial cells and within gland lumina. On the other hand, T cells, NK cells, macrophages, and neutrophils do not show a different pattern compared with non-pathological endometrium [24, 43, 44]. For this reason, it can be assumed that CE inflammation relies on a B cell response. More specifically, CE is characterized by a specific Ig-class expression. CE endometrium has a higher density of Ig-bearing endometrial stromal cells than in physiological endometrium. The density of IgM+, IgA1+, IgA2+, IgG1+, and IgG2+ is higher, but IgG2+ is the most predominant and peculiar Ig-class in CE [45]. In particular, IgG2 is the main effector against bacterial capsular poly-saccharide antigens [46]. For this reason, this unique Ig subclass expression in CE is likely to result from in situ production of endometrial plasmacyte infiltrates as a response to infectious trigger [45].

Over the last 30 years, there has been growing interest in a peculiar class of leukocytes in relation to embryo implantation, namely the uNK. These cells have been detected in areas of stromal decidualization, including progesterone-treated endometrium, intrauterine decidua in ectopic pregnancy, and extrauterine decidua in normal pregnancy. They probably play a role in correct decidualization by promoting adequate vascular remodeling [47, 48]. In CE, during the endometrial secretory phase, the endometrium showed a lower percentage of uterine NK cell (CD56+ CD16- and CD56brightCD16-) [49]. This finding may suggest that a different leukocyte pattern may affect endometrial decidualization in CE and, subsequently, embryo implantation. Furthermore, in order to clarify the immunomodulation role of uNK cells, we considered that uNK cells, but not peripheral blood NK cells, were found to selectively express the genes of immunomodulatory proteins. In particular, they express glycodelin and galectin-1, tetraspanins, integrins, lectin-like receptors, and inhibitory receptors in early pregnancy (KIRs) providing a locally immunosuppressive environment at the maternal-fetal interface [50,51,52,53].

Thus, uNK are probably involved in both proper endometrial vascularization and immunomodulation. On the contrary, in CE endometrium, a decrease in these cells is observed which may probably impair implantation.

With regard to T lymphocytes, Matteo et al. found a higher percentage of CD3+ cells in CE endometrium and, in particular, the percentage of CD4 cells resulted significantly higher [49]. Interestingly, previous studies have confirmed the important role of Treg cells in regulating local immunomodulation during the implantation window. The semi-allogenic embryo transplantation is tolerated by a peculiar balance of Th1/Th2 and Th17/Treg cell immune responses [54]. In particular, Tregs suppress maternal alloreactive immune responses against paternal antigens in trophoblast thanks to the production of TGF-β and IL-10, anti-inflammatory mediators. Moreover, among the CD4+ T cells, approximately 10 to 30% express the Treg transcription factor FOXP3. A complex interaction between uNK and Tregs and proper vascularization and decidualization are under study. For this reason, an unstable balance of T cells can affect the acceptation of the embryo by the endometrium [39].

Altered uterine contractility

Under normal conditions, a varied wave contractility pattern is present in the endometrium for the duration of the menstrual cycle. From an academic perspective, the contractility waves can be divided into three patterns: fundus to cervix (anterograde), cervix to fundus (retrograde), opposing (conflicting waves starting simultaneously on the fundus and the cervix and meeting in the middle of the uterus), not propagating (myometrial activity starting chaotically from different sites), and absent. In addition, cycle-dependent changes can also be observed in the characteristics of endometrial wave (EW) patterns. More specifically, during the early follicular phase anterograde, EWs predominate and are characterized by high amplitude and frequency. For the duration of the periovulatory phase, EWs are, for the most part, retrograde. EW activity is, to a large extent, absent throughout the secretory phase. From a physiologic and clinical perspective, it has been speculated that the purpose of anterograde EW is to empty the uterine cavity during the menstrual and early proliferation phases. It may be that retrograde EW during the periovulatory phase is connected with the active transport of sperm from the vagina to the fallopian tubes, while the quiescent status in the luteal phase may facilitate the process of embryo implantation [55,56,57,58].

Pinto et al. in 2015 studied the uterine contractility in non-pregnant women with CE and demonstrated that cycle-dependent uterine contractility is altered in women affected by CE [59]. In particular:

  1. 1

    CE EW showed a 3.3 times lower occurrence of retrograde contractions during the periovulatory phase compared with non-CE uterus.

  2. 2

    CE EW in midluteal phase showed a propagating contractile activity that was either anterograde or retrograde in 20% of cases. By contrast, non-CE EWs were local and non-propagating.

The EWs originate from the junctional zone (JZ), which is the transitional interface between the endometrium and the outer myometrium [60]. Different endometrial and myometrial pathologies can potentially cause alterations of the JZ thickness and activity, such as adenomyosis and fibroids [61]. For this reason, Pinto speculated that even the chronic inflammatory process, which occurs in chronic endometritis, could affect JZ functionality. In fact, the altered leukocyte population and the altered pattern of paracrine factors could influence the nearby endometrium of the JZ, inducing an altered contractility which can lead to infertility.

Altered vascularization

Blood vessels are important players in the inflammatory process. Moreover, they are the principal morphological element of functional polyps, where large caliber arterialized vessels are seen in the functional layer. For this reason, a new interest has grown in detecting relationships between polyps and CE. Starting with this consideration, we considered the following study.

Alterations in blood vessels in CE secretive endometrium were studied by Carvalho (2013) [62]. The chief anatomopathological modifications in CE are, in descending order:

  1. 1

    High vascular density with endothelial proliferation and swelling associated with hyaline vascular wall thickening with luminal occlusion

  2. 2

    Hyaline thickening of the vascular wall with luminal occlusion

  3. 3

    High vascular density with endothelial proliferation and swelling

  4. 4

    High vascular density with endothelial proliferation and swelling associated with small vessel thrombosis

  5. 5

    Hyaline vascular wall thickening with luminal occlusion and small vessel thrombosis

  6. 6

    High vascular density with endothelial proliferation and swelling associated with hyaline vascular wall thickening with luminal occlusion and thrombosis of small vessels

  7. 7

    High vascular density with endothelial proliferation and swelling associated with hyaline vascular wall thickening with luminal occlusion with luminal occlusion and segmented fibrinoid degeneration

  8. 8

    Small-vessel thrombosis.

According to the study, in 85.7% of cases, vascular changes were associated with CE, while CE without vascular changes was observed in only 7.3% of cases. It was specifically noted that these vascular alterations are almost identical to the thick-walled vessels along the vascular axis of polyps. As a result of these observations, it can be hypothesized that the vessel axis of polyps may represent a developing stage of vasculopathy related to CE. Furthermore, the close relation between endometritis, polyps, and infertility is currently being studied [63]. The relationship between endometrial polyps and CE has recently been investigated, and one of the principal outcomes has been that EPs are often immunoreactive for CD-138, implying a possible role of chronic endometrial inflammation in their pathogenesis [64]. In all probability, these three diseases share a unique pathological substrate, and inflammation is the most likely candidate. However, further studies are needed to prove this relationship.

These pathological findings have the potential to impede endometrium receptivity, and subsequently implantation, in a range of different ways. Firstly, that increased vessel density is associated with recurrent early pregnancy loss must be taken into consideration. A possible reason for this may be found in the increase of environment oxygenation in the early phase of implantation, owing to the harmful effect of reactive oxygen species. By contrast, normal placental development takes place in a relatively hypoxic environment [48]. Secondly, flow reserve could be impaired by swelling, endothelial proliferation, small-vessel thrombosis, and luminal occlusion. This consideration could be comparable to microcirculation pathology in the myocardium. In this situation, when microvessels are affected by luminal stenosis, coronary flow reserve is reduced [65]. Analogously, it could be conjectured that what we can define as “endometrial flow reserve” can be affected by luminal impairment. Specifically, this blood perfusion could be reduced in instances where it is requested for placental development. To summarize, both excessive and reduced vascular efficiency may lead to a deleterious success for embryo implantation.

Altered decidualization

Endometrial stromal cells (ESCs) participate in the process of decidualization. Estrogen and progesterone modulate decidua in order to facilitate embryo implantation and IGF-1 and IGF-2 are mediators for hormone actions [31]. In particular, estrogen stimulates IGF-I gene expression in the endometrium [66] and IGF-II is upregulated in decidualized endometrium in women treated with levonorgestrel [67]. However, more studies are needed to clarify the relationship between the IGF pathway and sexual hormones in decidualization.

At the beginning of this cascade, it is important to understand that the estrogen receptor (ER) expression reaches a peak in the early proliferative phase with a slight decrease in the late proliferative and early secretory phases in both glandular and stromal endometrium. It then shows a marked decrease in the late secretory phase, specifically in glandular cells. On the other hand, the progesterone receptor (PR) expression increases gradually in the proliferative and secretory phases and decreases in the late secretory phase, especially in the glandular cells [68].

This hormonal pattern is a leading promoter of decidualization. Specifically, decidua allows nutrition and gas and waste exchanges between the fetus and mother in cooperation with the placenta and also produces hormones, growth factors, and cytokines such as prolactin (PRL), corticotrophin-releasing factor (CRF), insulin-like growth factor binding protein-1 (IGFBP-1), and interleukin-15. Decidua probably also modulates trophoblast invasion and maternal immune system tolerance [69,70,71].

Two studies were considered in order to clarify the role of CE in endometrium decidualization: Wu (2017) and Mishra (2008), who both studied the impact of CE on decidualization [34, 72]. The main findings can be summarized as follows:

  1. 1

    PRL and IGFBP-1 are markers of decidualization and are both decreased in CE [34]. Importantly, PRL level expression decrease has been previously correlated with spontaneous early pregnancy loss. In particular, PRL role in embryo implantation can be related to detrimental peptides inhibition (e.g., IL-2) and cytokine stimulation (e.g., TNF-a). Consequently, these cytokines can recruit immune cells, sensitize the ESCs to Fas-mediated apoptosis, and promote the release of molecules that interact with the blastocyst and allow a successful implantation [73]. By contrast, IGFBP-1 is part of a more complex pathway, the forkhead transcription factor, forkhead box O1A (FOXO1). In particular, IGFBP-1 plays a role in endometrial cell differentiation [74].

  2. 2

    In patients suffering from both endometriosis and CE, the concentration of PRL and IGFBP-1 produced tend to be lower compared with that in patients with endometriosis without CE [34].

  3. 3

    It is likely that the decrease in PRL and IGFBP-1 has its origin in gene expression. The mRNA levels of both, indeed, are lower in CE. As above, in this case, a similar tendency is also noted in patients with endometriosis [34].

  4. 4

    In ESCs, expressions of ERα and ERβ (estrogen receptors α and β) and PRA and PRB (progesterone receptors A and B) are higher in CE endometrium than in non-CE endometrium [34, 72].

  5. 5

    The cell number of decidualized ESCs is increased in CE decidua [34]. In particular, a clear cell proliferation can be noticed if considered Ki-67. Ki-67 is a marker of cell proliferation and its expression in the endometrial cells reaches a peak in the follicular phase and then decreases by half during the early luteal phase and drops during the mid- and late-luteal phase. Ki-67 in the endometrial glandular and stromal cells is significantly higher in both granulomatous and CE than the control group [72].

This data suggests that CE modifies decidualization. In particular, CE slows down decidua maturation by reducing estrogen and progesterone action. If the real cause is unknown, we can probably observe that the receptors are upregulated and speculate that inflammation may be responsible for sexual-steroid resistance. Previously, it was noticed that the loss of PR activity during early pregnancy resulted in the resorption of implantation sites [75]. Moreover, it has been proven that progesterone promotes ESC differentiation [76]. ERα and PRA are the predominant isoforms that mediate the critical functions of the uterus for the embryo implantation and maintenance of pregnancy [77, 78]. Taken together, these findings can help hypothesize that estrogen and progesterone action is decreased in CE endometrium and lead to altered embryo implantation.

To conclude, we can speculate that there are a less differentiation stimulus and a greater potential to proliferation in CE endometrium, which results in a greater number of ESCs with reduced commitment. As a result, the abnormal expression of sex hormone receptors linked to a greater ESCs number brings about the difficulty for the endometrium to prepare the field for a correct implantation.

Altered autophagy

Autophagy is a mechanism of lysosome-mediated protein degradation that is necessary in maintaining cellular homeostasis by recycling amino acids, reducing the amount of damaged proteins, and modulating intracellular protein levels in response to extracellular signals. In particular, autophagy has important effects on the induction and modulation of the inflammatory reaction, modulates Treg cells, supports their lineage stability, and increases their life-expectancy [79].

Considering the fact that CE is associated with increased pro-inflammatory immune responses, it has been demonstrated that in CE endometrium, the level of microtubule-associated protein 1A/ 1B-light chain 3 (LC3-II protein) is significantly higher, while the level of mTORC1 is significantly lower than in controls [37].

Firstly, it must be considered that LC3-II is the transmembrane form of LC3, a soluble protein that is distributed ubiquitously in mammalian tissues. LC3 exists in two forms: a cytosolic form (LC3-I) and a lipid phosphatidylethanolamine-conjugated form (LC3-II) that is inserted into both inner and outer membranes of the autophagosome. Increased numbers of LC3-containing vesicles and increased LC3 flux indicate active autophagosome formation and clearance [80]. However, LC3 increase can be detrimental for cells and promote cell death which could possibly impair endometrial cells and lead to altered implantation [81].

Conversely, mTOR is a regulator of cellular metabolism and has a crucial role in regulating cellular autophagy [82]. mTOR action relies on integrating signals from the environment to the nucleus for the regulation of cell metabolism, proliferation, survival, and autophagy. Indeed, mTOR action in the placenta is positively correlated with birth weight of the infant [83]. In particular, mTOR is an autophagy negative modulator and modifies inflammatory responses by modulating immunoproteasomal degradation [84]. Furthermore, mTOR has a key role in the post-implantation period and its reduction can lead to reduced feto-placental growth and increased resorption rate [85].

Our pathophysiological model speculates on the integrating role of both LC3 and mTOR in CE endometrium in implantation. In particular, autophagy is enhanced, and this creates an unstable balance between proteins (or modulators) which should be released, and proteins which should be recycled, leading to an altered environment which is less receptive for implantation. Finally, according to previous findings, autophagy could have an important effect on the induction of inflammatory reaction in CE and sequential changes in local cytokine milieu.

Strength and limitations

This review includes all the studies about CE pathophysiology regarding altered implantation. However, most studies were primarily case-control, cohort studies, and retrospective. For this reason, various biases could arise from these study designs.


To the best of our knowledge, ours is the first summary of evidence on CE pathophysiology and its relationship with altered implantation. CE may affect female fertility in multiple ways, starting from an alteration of endometrial microbiota and continuing with inflammation and its secondary effects. Abnormal cytokines and leukocyte expression may impair the immune tolerance of the endometrium to the embryo and alter endometrial vascular permeability, potentially damaging embryo viability and trophoblast invasion. Additionally, abnormal uterine contractility during the midluteal phase may inhibit in vivo fertilization and affect transuterine migration of the embryo before implantation. Finally, altered autophagy may affect endometrial cell commitment and impair endometrial decidualization in women with CE. Figure 1 summarizes all the findings and helps visualizing the complexity of our model regarding the chronic endometritis pathway.

Fig. 1

Chronic endometritis pathway

Data availability

All data are provided with this review.


  1. 1.

    Cicinelli E, Matteo M, Trojano G, Mitola PC, Tinelli R, Vitagliano A, et al. Chronic endometritis in patients with unexplained infertility: prevalence and effects of antibiotic treatment on spontaneous conception. Am J Reprod Immunol. 2017;79(1).

  2. 2.

    Cicinelli E, De Ziegler D, Nicoletti R. Chronic endometritis : correlation among hysteroscopic , histologic , and bacteriologic findings in a prospective trial with 2190 consecutive office hysteroscopies. Fertil Steril. 2008;89:677–84.

    PubMed  Google Scholar 

  3. 3.

    Greenwood SMMJ. Chronic endometritis: morphologic and clinical observations. Obstet Gynecol. 1981;58:176–84.

    CAS  PubMed  Google Scholar 

  4. 4.

    Cravello L, Porcu G, D'Ercole C, Roger V, Blanc B. Reconnaître et traiter une endométrite [Identification and treatment of endometritis]. Contracept Fertil Sex. 1997;25(7–8):585–6.

    CAS  PubMed  Google Scholar 

  5. 5.

    Kiviat NB, Wolner-Hanssen P, Eschenbach DA, Wasserheit JN, Paavonen JA, Bell TA, et al. Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol. 1990;14(2):167–75.

    CAS  PubMed  Google Scholar 

  6. 6.

    Kamiyama S, Teruya Y, Nohara M, Kanazawa K. Impact of detection of bacterial endotoxin in menstrual effluent on the pregnancy rate in in vitro fertilization and embryo transfer. Fertil Steril. 2004;82:788–92.

    PubMed  Google Scholar 

  7. 7.

    Liu Y, Phil M, Chen X, Ph D, Huang J, Ph D, et al. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure. Fertil Steril. 2018;109:832–9.

    PubMed  Google Scholar 

  8. 8.

    Moreno I, Cicinelli E, Bs IG, Bs MG, Bau D, Vilella F, et al. The diagnosis of chronic endometritis in infertile asymptomatic women : a comparative study of. Am J Obstet Gynecol. 2018;218:602.e1–602.e16.

    Google Scholar 

  9. 9.

    Cicinelli E, De Ziegler D, Nicoletti R, Tinelli R, Saliani N, Resta L, et al. Poor reliability of vaginal and endocervical cultures for evaluating microbiology of endometrial cavity in women with chronic endometritis. Gynecol Obstet Investig. 2009;68:108–15.

    Google Scholar 

  10. 10.

    Kitaya K, Matsubayashi H, Takaya Y, Nishiyama R, Yamaguchi K, Takeuchi T, et al. Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure. Am J Reprod Immunol. 2017;78(5).

  11. 11.

    Quaas A, Dokras A. Diagnosis and treatment of unexplained infertility. Rev Obstet Gynecol. 2008;1:69–77.

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Cicinelli E, Matteo M, Tinelli R, Pinto V, Marinaccio M, Indraccolo U, et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci. 2014;21(5):640–7.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Park HJ, Kim YS, Yoon TK, Lee WS. Chronic endometritis and infertility. Clin Exp Reprod Med. 2016;43:185–92.

    PubMed  PubMed Central  Google Scholar 

  14. 14.

    Song D, Feng X, Zhang Q, Xia E, Xiao Y, Xie W, et al. Prevalence and confounders of chronic endometritis in premenopausal women with abnormal bleeding or reproductive failure. Reprod BioMed Online. 2018;36:78–83.

    PubMed  Google Scholar 

  15. 15.

    Cicinelli E, Vitagliano A, Kumar A, Lasmar RB, Bettocchi S, Haimovich S, et al. Unified diagnostic criteria for chronic endometritis at fluid hysteroscopy: proposal and reliability evaluation through an international randomized-controlled observer study. Fertil Steril. 2019;112:162–173.e2.

    PubMed  Google Scholar 

  16. 16.

    Bayer-Garner IB, Korourian S. Plasma cells in chronic endometritis are easily identified when stained with syndecan-1. Mod Pathol. 2001;14:877–9.

    CAS  PubMed  Google Scholar 

  17. 17.

    Kasius JC, Broekmans FJM, Sie-Go DMDS, Bourgain C, Eijkemans MJC, Fauser BC, et al. The reliability of the histological diagnosis of endometritis in asymptomatic IVF cases: a multicenter observer study. Hum Reprod. 2012;27:153–8.

    CAS  PubMed  Google Scholar 

  18. 18.

    Kannar V, Lingaiah HK, Sunita V. Evaluation of endometrium for chronic endometritis by using syndecan-1 in abnormal uterine bleeding. J Lab Physicians. 2012;4:69.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Vitagliano A, Saccardi C, Litta P, Noventa M. Chronic endometritis : really so relevant in repeated IVF failure? Am J Reprod Immunol. 2017;78(6).

  20. 20.

    Vitagliano A, Saccardi C, Noventa M, Di Spiezio Sardo A, Saccone G, Cicinelli E, et al. Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure : a systematic review and meta-analysis. Fertil Steril. 2018;103–112.e1.

  21. 21.

    Johnston-MacAnanny EB, Hartnett J, Engmann LL, Nulsen JC, Sanders MM, Benadiva CA. Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril. 2010;93:437–41.

    PubMed  Google Scholar 

  22. 22.

    Vitagliano A, Noventa M, Gizzo S. Autoimmunity, systemic inflammation, and their correlation with repeated implantation failure and recurrent miscarriage: is chronic endometritis the missing piece of the jigsaw?. Am J Reprod Immunol. 2017;77(1).

  23. 23.

    Mcqueen DB, Bernardi LA, Stephenson MD. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril. 2014;101:1026–30.

    PubMed  Google Scholar 

  24. 24.

    Kitaya K, Yasuo T. Aberrant expression of selectin E, CXCL1, and CXCL13 in chronic endometritis. Mod Pathol. 2010;23(8):1136–46.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Kushnir VA, Solouki S, Sarig-Meth T, Vega MG, Albertini DF, Darmon SK, et al. Systemic inflammation and autoimmunity in women with chronic endometritis. Am J Reprod Immunol. 2016;75:672–7.

    CAS  PubMed  Google Scholar 

  26. 26.

    Espinoza J, Erez O, Romero R. Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery. Am J Obstet Gynecol. 2006;194:630–7.

    CAS  PubMed  Google Scholar 

  27. 27.

    Liu Y, Ko EYL, Wong KKW, Chen X, Cheung WC, Law TSM, et al. Endometrial microbiota in infertile women with and without chronic endometritis as diagnosed using a quantitative and reference range-based method. Fertil Steril. 2019;112:707–717.e1.

    PubMed  Google Scholar 

  28. 28.

    Santos CMA, Pires MCV, Leão TL, Hernández ZP, Rodriguez ML, Martins AKS, et al. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment. Microbiol (United Kingdom). 2016;162:1195–207.

    CAS  Google Scholar 

  29. 29.

    Sochocka M, Zwolińska K, Leszek J. The infectious etiology of Alzheimer’s disease. Curr Neuropharmacol. 2017;15:996–1009.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9:7204–18.

    PubMed  Google Scholar 

  31. 31.

    Di Pietro C, Cicinelli E, Guglielmino MR, Ragusa M, Farina M, Palumbo MA, et al. Altered transcriptional regulation of cytokines, growth factors, and apoptotic proteins in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol. 2013;69:509–17.

    PubMed  Google Scholar 

  32. 32.

    Di Pietro C, Caruso S, Battaglia R, Iraci M, La A, Fabrizio F, et al. MiR-27a-3p and miR-124-3p, upregulated in endometrium and serum from women affected by chronic endometritis, are new potential molecular markers of endometrial receptivity. Am J Reprod Immunol. 2018;80:e12858.

    PubMed  Google Scholar 

  33. 33.

    Dimitriadis E, Menkhorst E, Salamonsen LA, Paiva P. Review: LIF and IL11 in trophoblast-endometrial interactions during the establishment of pregnancy. Placenta. 2010;31:S99–104.

    PubMed  Google Scholar 

  34. 34.

    Wu D, Kimura F, Zheng L, Ishida M, Niwa Y, Hirata K, et al. Chronic endometritis modifies decidualization in human endometrial stromal cells. Reprod Biol Endocrinol. 2017;15(1):16.

    PubMed  PubMed Central  Google Scholar 

  35. 35.

    Giudice LC. Multifaceted roles for IGFBP-1 in human endometrium during implantation and pregnancy. Ann N Y Acad Sci. 1997;828:146–56.

    CAS  PubMed  Google Scholar 

  36. 36.

    Feng Y, Ma X, Deng L, Yao B, Xiong Y, Wu Y, et al. Role of selectins and their ligands in human implantation stage. Glycobiology. 2017;27:385–91.

    CAS  PubMed  Google Scholar 

  37. 37.

    Wang D, Sai J, Richmond A. Cell surface heparan sulfate participates in CXCL1-induced signaling. Biochemistry. 2003;42:1071–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Wang WJ, Zhang H, Chen ZQ, Zhang W, Liu XM, Fang JY, et al. Endometrial TGF-β, IL-10, IL-17 and autophagy are dysregulated in women with recurrent implantation failure with chronic endometritis. Reprod Biol Endocrinol. 2019;17(1):2.

    PubMed  PubMed Central  Google Scholar 

  39. 39.

    Robertson SA, Care AS, Moldenhauer LM. Regulatory T cells in embryo implantation and the immune response to pregnancy. J Clin Invest. 2018;128:4224–35.

    PubMed  PubMed Central  Google Scholar 

  40. 40.

    Wang X, Tian F, Chen C, Feng Y, Sheng X, Guo Y, et al. Exosome-derived uterine microRNAs isolated from cows with endometritis impede blastocyst development. Reprod Biol. 2019;19:204–9.

    CAS  PubMed  Google Scholar 

  41. 41.

    Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12:584–96.

    CAS  PubMed  Google Scholar 

  42. 42.

    Qu X, Tang Y, Hua S. Immunological approaches towards cancer and inflammation: a cross talk. Front Immunol. 2018;9:563.

    PubMed  PubMed Central  Google Scholar 

  43. 43.

    Kitaya K, Tada Y, Taguchi S, Funabiki M, Hayashi T, Nakamura Y. Local mononuclear cell infiltrates in infertile patients with endometrial macropolyps versus micropolyps. Hum Reprod. 2012;27:3474–80.

    CAS  PubMed  Google Scholar 

  44. 44.

    Disep B, Innes BA, Cochrane HR, Tijani S, Bulmer JN. Immunohistochemical characterization of endometrial leucocytes in endometritis. Histopathology. 2004;45:625–32.

    CAS  PubMed  Google Scholar 

  45. 45.

    Kitaya K, Tada Y, Hayashi T, Taguchi S, Funabiki M, Nakamura Y. Comprehensive endometrial immunoglobulin subclass analysis in infertile women suffering from repeated implantation failure with or without chronic endometritis. Am J Reprod Immunol. 2014;72:386–91.

    CAS  PubMed  Google Scholar 

  46. 46.

    Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:1–17.

    CAS  Google Scholar 

  47. 47.

    Bulmer JN, Lash GE. Uterine natural killer cells: time for a re-appraisal? F1000Research. 2019;8:999.

    CAS  Google Scholar 

  48. 48.

    Chen X, Man GCW, Liu Y, Wu F, Huang J, Li TC, et al. Physiological and pathological angiogenesis in endometrium at the time of embryo implantation. Am J Reprod Immunol. 2017;78:1–7.

    Google Scholar 

  49. 49.

    Matteo M, Cicinelli E, Greco P, Massenzio F, Baldini D, Falagario T, et al. Abnormal pattern of lymphocyte subpopulations in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol. 2009;61:322–9.

    PubMed  Google Scholar 

  50. 50.

    Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, et al. Human decidual natural killer cells are a unique NK cell subset with Immunomodulatory potential. J Exp Med. 2003;198:1201–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Croy BA, Ashkar AA, Minhas K, Greenwood JD. Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia? J Soc Gynecol Investig. 2000;12–20.

  52. 52.

    Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod. 1995;10:14–21.

    CAS  PubMed  Google Scholar 

  53. 53.

    Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 2005;26:44–62.

    CAS  PubMed  Google Scholar 

  54. 54.

    Polese B, Gridelet V, Araklioti E, Martens H, d’Hauterive SP, Geenen V. The endocrine milieu and CD4 T-lymphocyte polarization during pregnancy. Front Endocrinol (Lausanne). 2014;5:1–11.

    Google Scholar 

  55. 55.

    Oki T, Douchi T, Maruta K, Nakamura S, Nagata Y. Changes in endometrial wave-like movements in accordance with the phases of menstrual cycle. 2002;28(3):176–81.

  56. 56.

    Kunz G, Noe M, Herbertz M, Leyendecker G. Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update. 1998;4:647–54.

    CAS  PubMed  Google Scholar 

  57. 57.

    Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod. 1996;11:627–32.

    CAS  PubMed  Google Scholar 

  58. 58.

    Fanchin R, Ayoubi JM, Righini C, Olivennes F, Schonauer LM, Frydman R. Uterine contractility decreases at the time of blastocyst transfer. Hum Reprod. 2001;16:1115–9.

    CAS  PubMed  Google Scholar 

  59. 59.

    Pinto V, Matteo M, Tinelli R, Mitola PC. Altered uterine contractility in women with chronic endometritis. Fertil Steril. Elsevier Inc. 2015;103:1049–52.

    PubMed  Google Scholar 

  60. 60.

    Naftalin J, Jurkovic D. The endometrial-myometrial junction: a fresh look at a busy crossing. Ultrasound Obstet Gynecol. 2009;34:1–11.

    CAS  PubMed  Google Scholar 

  61. 61.

    Tanos V, Balami S, Lingwood L. Junctional zone endometrium alterations in gynecological and obstetrical disorders and impact on diagnosis, prognosis and treatment. Curr Opin Obstet Gynaecol. 2019;31:418–27.

    Google Scholar 

  62. 62.

    Carvalho FM, Aguiar FN, Tomioka R, de Oliveira RM, Frantz N, Ueno J. Functional endometrial polyps in infertile asymptomatic patients: a possible evolution of vascular changes secondary to endometritis. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):152–6.

    Article  PubMed  Google Scholar 

  63. 63.

    Kim MR, Ah Kim Y, Jo MY, Hwang KJ, Ryu HS. High frequency of endometrial polyps in endometriosis. J Am Assoc Gynecol Laparosc. 2003;10:46–8.

    PubMed  Google Scholar 

  64. 64.

    Cicinelli E, Bettocchi S, de Ziegler D, Loizzi V, Cormio G, Marinaccio M, et al. Chronic endometritis, a common disease hidden behind endometrial polyps in premenopausal women: first evidence from a case-control study. J Minim Invasive Gynecol. Elsevier Inc. 2019;26:1346–50.

    PubMed  Google Scholar 

  65. 65.

    Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of ischemic heart disease: fundamental role of coronary microvascular dysfunction in the pathogenesis of angina pectoris. Circulation. 2018;138:1463–80.

    PubMed  Google Scholar 

  66. 66.

    Rutanen EM. Insulin like growth factors in endometrial function. Gynecol Endocrinol. 1998;12:399–406.

    CAS  PubMed  Google Scholar 

  67. 67.

    Rutanen EM. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery. Hum Reprod. 2000;15:173–81.

    CAS  PubMed  Google Scholar 

  68. 68.

    Felix JC, Farahmand S. Endometrial glandular proliferation and estrogen receptor content during the normal menstrual cycle. Contraception. 1997;55:19–22.

    CAS  PubMed  Google Scholar 

  69. 69.

    Petraglia F, Tabanelli S, Galassi MC, Garuti GC, Mancini AC, Genazzani AR, et al. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. J Clin Endocrinol Metab. 1992;74:1427–31.

    CAS  PubMed  Google Scholar 

  70. 70.

    Telgmann R, Gellersen B. Marker genes of decidualization: activation of the decidual prolactin gene. Hum Reprod Update. 1998;4:472–9.

    CAS  PubMed  Google Scholar 

  71. 71.

    Makrigiannakis A, Margioris AN, Chatzaki E, Zoumakis E, Chrousos GP, Gravanis A. The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells. Mol Hum Reprod. 1999;5:789–96.

    CAS  PubMed  Google Scholar 

  72. 72.

    Mishra K, Wadhwa N, Guleria K, Agarwal S. ER , PR and Ki-67 expression status in granulomatous and chronic non-specific endometritis. I Obstet Gynaecol Res. 2008;34:371–8.

    CAS  Google Scholar 

  73. 73.

    Garzia E, Clauser R, Persani L, Borgato S, Bulfamante G, Avagliano L, et al. Prolactin and proinflammatory cytokine expression at the fetomaternal interface in first trimester miscarriage. Fertil Steril. 2013;100:108–15.

    CAS  PubMed  Google Scholar 

  74. 74.

    Takano M, Lu Z, Goto T, Fusi L, Higham J, Francis J, et al. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. Mol Endocrinol. 2007;21:2334–49.

    CAS  PubMed  Google Scholar 

  75. 75.

    Mestre-Citrinovitz AC, Kleff V, Vallejo G, Winterhager E, Saragüeta P. A suppressive antagonism evidences progesterone and estrogen receptor pathway interaction with concomitant regulation of Hand2, Bmp2 and ERK during early decidualization. PLoS One. 2015;10:1–20.

    Google Scholar 

  76. 76.

    Okada H, Sanezumi M, Nakajima T, Okada S, Yasuda K, Kanzaki H. Rapid down-regulation of CD63 transcription by progesterone in human endometrial stromal cells. Mol Hum Reprod. 1999;5:554–8.

    CAS  PubMed  Google Scholar 

  77. 77.

    Conneely OM, Lydon JP. Progesterone receptors in reproduction: functional impact of the a and B isoforms. Steroids. 2000;65:571–7.

    CAS  PubMed  Google Scholar 

  78. 78.

    Hewitt SC, Korach KS. Oestrogen receptor knockout mice: roles for estrogen receptors alpha and beta in reproductive tissues. Repruduction. 2003;125:143–9.

    CAS  Google Scholar 

  79. 79.

    Netea-Maier RT, Plantinga TS, van de Veerdonk FL, Smit JW, Netea MG. Modulation of inflammation by autophagy: consequences for human disease. Autophagy. 2016;12:245–60.

    CAS  PubMed  Google Scholar 

  80. 80.

    Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol. 2008;445:77–88.

    CAS  PubMed  Google Scholar 

  81. 81.

    Kang W, Ishida E, Yamatoya K, et al. Autophagy-disrupted LC3 abundance leads to death of supporting cells of human oocytes. Biochem Biophys Rep. 2018;15:107–14. Published 2018 Aug 21.

    Article  PubMed  PubMed Central  Google Scholar 

  82. 82.

    Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–41.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  83. 83.

    Jansson N, Rosario FJ, Gaccioli F, Lager S, Jones HN, Ross S, et al. Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab. 2012;98:105–13.

    PubMed  PubMed Central  Google Scholar 

  84. 84.

    Zhang B, Fang L, Wu HM, Ding PS, Xu K, Liu RY. Mer receptor tyrosine kinase negatively regulates lipoteichoic acid-induced inflammatory response via PI3K/Akt and SOCS3. Mol Immunol. 2016;76:98–107.

    CAS  PubMed  Google Scholar 

  85. 85.

    Roberti SL, Higa R, White V, Powell TL, Jansson T, Jawerbaum A. Critical role of mTOR, PPARγ and PPARδ signaling in regulating early pregnancy decidual function, embryo viability and feto-placental growth. Basic Sci Reprod Med. 2018;24:327–40.

    CAS  Google Scholar 

Download references


Open access funding provided by Università degli Studi di Padova within the CRUI-CARE Agreement.

Author information




G. Buzzaccarini: Data collection or management, data analysis, manuscript writing, and revision process.

A. Vitagliano: project development, data analysis, and manuscript editing.

A. Andrisani: Manuscript editing.

C.M. Santarsiero: Data collection or management, data analysis, and manuscript writing.

R. Cicinelli: Data collection or management, data analysis, and manuscript writing.

C. Nardelli: Manuscript editing.

G. Ambrosini: Revision process.

E. Cicinelli: Project development, data analysis, and manuscript editing.

Corresponding author

Correspondence to Giovanni Buzzaccarini.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Buzzaccarini, G., Vitagliano, A., Andrisani, A. et al. Chronic endometritis and altered embryo implantation: a unified pathophysiological theory from a literature systematic review. J Assist Reprod Genet 37, 2897–2911 (2020).

Download citation


  • Chronic endometritis
  • Infertility
  • Pathophysiology
  • IVF
  • Embryo transfer
  • Recurrent pregnancy failures
  • Recurrent pregnancy loss